Key terms

About MLTX

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest MLTX news

Today 2:55pm ET Strong Buy Rating for MoonLake Immunotherapeutics Based on Promising Sonelokimab Clinical Trials and Market Potential by TipRanks Apr 24 5:58am ET 3 Best Stocks to Buy Now, 4/24/2024, According to Top Analysts by TipRanks Apr 23 6:25am ET MoonLake Immunotherapeutics: A Promising Outlook with Sonelokimab’s Potential in the HS Market by TipRanks Apr 22 12:35pm ET Buy Rating Affirmed for MoonLake Immunotherapeutics Amid Promising Clinical Results for Sonelokimab by TipRanks Apr 09 6:05am ET MoonLake Immunotherapeutics: A Strong Buy on Innovation and Strategic Market Positioning by TipRanks Apr 02 9:53am ET Estee Lauder upgraded, Petco downgraded: Wall Street’s top analyst calls by TipRanks Apr 02 4:54am ET MoonLake Immunotherapeutics initiated with a Neutral at Goldman Sachs by TipRanks Mar 21 8:33am ET Ascendis, MoonLake Immunotherapeutics removed from Best Ideas List at Wedbush by TipRanks Mar 14 3:29am ET 3 Best Stocks to Buy Now, 3/14/2024, According to Top Analysts by TipRanks Mar 13 2:00am ET Analysts Have Conflicting Sentiments on These Healthcare Companies: MoonLake Immunotherapeutics (MLTX), Structure Therapeutics, Inc. Sponsored ADR (GPCR) and Aligos Therapeutics (ALGS) by TipRanks Mar 11 9:10am ET Analysts Offer Insights on Healthcare Companies: Geron (GERN), Merus (MRUS) and MoonLake Immunotherapeutics (MLTX) by TipRanks Mar 11 8:12am ET MoonLake Immunotherapeutics Unveils Psoriatic Arthritis Breakthroughs by TipRanks Mar 11 7:40am ET Analysts Are Bullish on These Healthcare Stocks: MoonLake Immunotherapeutics (MLTX), Eli Lilly & Co (LLY) by TipRanks Mar 11 7:30am ET Analysts Offer Insights on Healthcare Companies: MoonLake Immunotherapeutics (MLTX) and Morphic Holding (MORF) by TipRanks Mar 11 6:50am ET Analysts Have Conflicting Sentiments on These Healthcare Companies: MoonLake Immunotherapeutics (MLTX), Janux Therapeutics Inc (JANX) and SAGE Therapeutics (SAGE) by TipRanks Mar 11 6:40am ET Analysts Offer Insights on Healthcare Companies: Trevena (TRVN), MoonLake Immunotherapeutics (MLTX) and Senseonics Holdings (SENS) by TipRanks Mar 11 6:20am ET Analysts’ Opinions Are Mixed on These Healthcare Stocks: MoonLake Immunotherapeutics (MLTX) and Enhabit, Inc (EHAB) by TipRanks Mar 11 6:16am ET MoonLake price target raised to $100 from $75 at H.C. Wainwright by TipRanks Mar 11 2:40am ET Analysts’ Opinions Are Mixed on These Healthcare Stocks: Illumina (ILMN), MoonLake Immunotherapeutics (MLTX) and Wave Life Sciences (WVE) by TipRanks Mar 10 4:06pm ET MoonLake announces improvements with Nanobody sonelokimab over 24 weeks in PsA by TipRanks Mar 05 12:14am ET 3 Best Stocks to Buy Now, 3/5/2024, According to Top Analysts by TipRanks Mar 01 8:14am ET MoonLake Immunotherapeutics price target raised to $80 from $77 at Guggenheim by TipRanks Mar 01 3:00am ET Analysts’ Opinions Are Mixed on These Healthcare Stocks: Jazz Pharmaceuticals (JAZZ), Puma Biotechnology (PBYI) and MoonLake Immunotherapeutics (MLTX) by TipRanks Feb 29 4:35pm ET MoonLake Immunotherapeutics: A Strong Buy on Clinical and Financial Milestones by TipRanks Feb 29 3:10pm ET Analysts’ Top Healthcare Picks: Chimerix (CMRX), MoonLake Immunotherapeutics (MLTX) by TipRanks Feb 29 1:20pm ET Analysts Offer Insights on Healthcare Companies: Theratechnologies (THTX), MoonLake Immunotherapeutics (MLTX) and DENTSPLY SIRONA (XRAY) by TipRanks Feb 29 8:02am ET MoonLake Immunotherapeutics reports Q4 EPS (12c), consensus (23c) by TipRanks Feb 28 2:09am ET 3 Best Stocks to Buy Now, 2/28/2024, According to Top Analysts by TipRanks Feb 27 11:39pm ET MoonLake Immunotherapeutics: A Promising Buy on Streamlined Clinical Progress and Regulatory Synergy by TipRanks Feb 27 6:30am ET Analysts Offer Insights on Healthcare Companies: BioCryst (BCRX), TransMedics Group (TMDX) and MoonLake Immunotherapeutics (MLTX) by TipRanks Feb 26 4:35pm ET MoonLake Immunotherapeutics: A Strong Buy on Robust Clinical Prospects and Strategic Phase 3 Advancements by TipRanks

No recent press releases are available for MLTX

MLTX Financials

1-year income & revenue

Key terms

MLTX Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

MLTX Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

Student demonstrators occupy the pro-Palestinian "Gaza Solidarity Encampment" on the West Lawn of Columbia University on April 24, 2024 in New York City.
Michael M. Santiago/Getty Images
What the pro-Palestinian protesters on college campuses actually want
People walk by the New York Stock Exchange (NYSE) on March 20, 2024 in New York City. The Dow was up slightly in late morning trading as traders analyze the Federal Reserve's latest decision on interest rates.
Spencer Platt/Getty Images
Stagflation fears just hit Wall Street. Now for the next crucial report on prices
Meta headquarters pictured on February 02, 2023 in Menlo Park, California.
Justin Sullivan/Getty Images
Meta’s stock plunges 15% on ‘aggressive’ AI spending plans
GettyImages-1159438448 copy.jpg
Lyndon Stratford/iStockphoto/Getty Images
Americans are falling behind on their payments